Skip to content

A SEARCH TO IDENTIFY ANY DRUG-DRUG INTERACTION AMONG PSYCHIATRY INPATIENTS IN A TERTIARY HEALTHCARE CENTRE

A STUDY TO IDENTIFY POTENTIAL DRUG-DRUG INTERACTION AMONG PSYCHIATRY INPATIENTS IN A TERTIARY HEALTHCARE CENTRE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047051
Enrollment
114
Registered
2022-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F068- Other specified mental disorders due to known physiological condition

Interventions

None listed

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants of either gender, age 18 years or above, admitted in the department of psychiatry, prescribed with at least two drugs(one of which was from the psychotropic class). All the participants with a psychiatric diagnosis as per the Tenth Revision of the International Classification of Diseases (ICD 10)

Exclusion criteria

Exclusion criteria: Participants referred to the psychiatric unit for evaluation. Participants or guardian not willing to give consent. Topical agents and drugs which were not included in any of the reference resources.

Design outcomes

Primary

MeasureTime frame
to determine the drugs associated with significant drug-drug interactions and the symptoms related to themTimepoint: baseline

Secondary

MeasureTime frame
â?¢ The information from the results can be used by the healthcare workers for better understanding of drug-drug interactions occurring in the psychiatric patients and avoid the same in the futureTimepoint: Baseline

Countries

India

Contacts

Public ContactDr Smitha

NGSM Institute of Pharmaceutical Sciences

junojoel@nitte.edu.in9480470727

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026